Monte Rosa Therapeutics, Inc. reports

Location
321 Harrison Avenue, Suite 900, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
9/14/2024, 04:05 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#2) Aug 12, 2024
SC 13D/A Report SC 13D/A Aug 12, 2024
10-Q Report | Data 10-Q Aug 8, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 8, 2024 Aug 8, 2024
8-K Report | Data 8-K Jun 27, 2024 Jun 27, 2024
8-K Report | Data 8-K Jun 12, 2024 Jun 12, 2024
8-K Report | Data 8-K May 30, 2024 May 28, 2024
8-K Report | Data 8-K May 16, 2024 May 15, 2024
SC 13D/A Report NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#1) May 13, 2024
10-Q Report | Data 10-Q May 9, 2024 Mar 31, 2024
8-K Report | Data 8-K May 9, 2024 May 9, 2024
8-K Report | Data 8-K May 2, 2024 Apr 29, 2024
SC 13G/A Report Apr 10, 2024
10-K Report | Data 10-K Mar 14, 2024 Dec 31, 2023
8-K Report | Data 8-K Mar 14, 2024 Mar 14, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report AMENDMENT NO. 3 Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report MONTE ROSA THERAPEUTICS, INC. Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report Feb 9, 2024
8-K Report | Data 8-K Jan 8, 2024 Jan 8, 2024
SC 13D/A Report SC 13D/A Nov 9, 2023
10-Q Report | Data 10-Q Nov 9, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 9, 2023 Nov 9, 2023
8-K Report | Data 8-K Oct 26, 2023 Oct 26, 2023
8-K Report | Data 8-K Oct 17, 2023 Oct 16, 2023
10-Q Report | Data 10-Q Aug 10, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 10, 2023 Aug 10, 2023
8-K Report | Data 8-K Jul 26, 2023 Jul 26, 2023
8-K Report | Data 8-K Jun 14, 2023 Jun 14, 2023
10-Q Report | Data 10-Q May 11, 2023 Mar 31, 2023
8-K Report | Data 8-K May 11, 2023 May 11, 2023
8-K Report | Data 8-K Mar 23, 2023 Mar 22, 2023
10-K Report | Data 10-K Mar 16, 2023 Dec 31, 2022
8-K Report | Data 8-K Mar 16, 2023 Mar 16, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report MONTE ROSA THERAPEUTICS, INC. Feb 14, 2023
SC 13G/A Report Feb 9, 2023
SC 13G Report Feb 3, 2023
8-K Report | Data 8-K Jan 9, 2023 Jan 9, 2023
10-Q Report | Data 10-Q Nov 10, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 10, 2022 Nov 10, 2022
8-K Report | Data FORM 8-K Oct 24, 2022 Oct 24, 2022
10-Q Report | Data 10-Q Aug 11, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 11, 2022 Aug 11, 2022
8-K Report | Data 8-K Jun 15, 2022 Jun 15, 2022
10-Q Report | Data 10-Q May 11, 2022 Mar 31, 2022
8-K Report | Data 8-K May 11, 2022 May 11, 2022
10-K Report | Data 10-K Mar 29, 2022 Dec 31, 2021
8-K Report | Data 8-K Mar 29, 2022 Mar 29, 2022
SC 13G/A Report Feb 14, 2022
SC 13G Report MONTE ROSA THERAPEUTICS, INC. Feb 11, 2022
SC 13G/A Report Feb 10, 2022
SC 13G Report Feb 10, 2022
SC 13G/A Report Feb 9, 2022
SC 13G/A Report Feb 9, 2022
SC 13G Report Feb 4, 2022
8-K Report | Data 8-K Jan 10, 2022 Jan 10, 2022
8-K Report | Data 8-K Dec 15, 2021 Dec 14, 2021
8-K Report | Data 8-K Nov 12, 2021 Nov 10, 2021
10-Q Report | Data 10-Q Nov 10, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 12, 2021 Jun 30, 2021
8-K Report | Data FORM 8-K Aug 12, 2021 Aug 12, 2021
SC 13G Report Aug 10, 2021
SC 13D Report NEW ENTERPRISE ASSOCIATES 17, L.P. / MONTE ROSA THERAPEUTICS, INC. -- SCHEDULE 1 Jul 12, 2021
SC 13D Report SC 13D Jul 8, 2021
SC 13G Report Jul 8, 2021
8-K Report 8-K Jun 28, 2021 Jun 28, 2021